Add like
Add dislike
Add to saved papers

Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.

INTRODUCTION: Radiolabeled bombesin (BBN)-analogs have been proposed for diagnosis and therapy of gastrin-releasing peptide receptor (GRPR)-expressing tumors, such as prostate, breast and lung cancer. Metabolic stability represents a crucial factor for the success of this approach by ensuring sufficient delivery of circulating radioligand to tumor sites. The amide-to-triazole switch on the backbone of DOTA-PEG4 -[Nle14 ]BBN(7-14) (1) was reported to improve the in vitro stability of resulting 177 Lu-radioligands. On the other hand, in-situ inhibition of neutral endopeptidase (NEP) by coinjection of phosphoramidon (PA) was shown to significantly improve the in vivo stability and tumor uptake of biodegradable radiopeptides. We herein compare the impact of the two methods on the bioavailability and localization of 177 Lu-DOTA-PEG4 -[Nle14 ]BBN(7-14) analogs in GRPR-positive tumors in mice.

METHODS: The 1,4-disubstituted [1-3]-triazole was used to replace one (2: Gly11 -His12 ; 3: Ala9 -Val10 ) or two (4: Ala9 -Val10 and Gly11 -His12 ) peptide bonds in 1 (reference) and all compounds were labeled with 177 Lu. Each of [177 Lu]1-[177 Lu]4 was injected without (control) or with PA in healthy mice. Blood samples collected 5min post-injection (pi) were analyzed by HPLC. Biodistribution of [177 Lu]1-[177 Lu]4 was conducted in SCID mice bearing human prostate adenocarcinoma PC-3 xenografts at 4h pi. Groups of 4 animals were injected with radioligand, alone (controls), or with coinjection of PA, or of a mixture of PA and excess and [Tyr4 ]BBN to determine GRPR-specificity of uptake (Block).

RESULTS: The in vivo stability of the radioligands was: [177 Lu]1 (25% intact), [177 Lu]2 (45% intact), [177 Lu]3 (30% intact) and [177 Lu]4 (40% intact). By PA-coinjection these values notably increased to 90%-93%. Moreover, treatment with PA induced an impressive and GRPR-specific uptake of all radioligands in the PC-3 xenografts at 4h pi: [177 Lu]1: 4.7±0.4 to 24.8±4.9%ID/g; [177 Lu]2: 8.3±1.2 to 26.0±1.1%ID/g; [177 Lu]3: 6.6±0.4 to 21.3±4.4%ID/g; and [177 Lu]4: 4.8±1.6 to 13.7±3.8%ID/g.

CONCLUSIONS: This study has shown that amide-to-triazole substitutions in 177 Lu-DOTA-PEG4 -[Nle14 ]BBN(7-14) induced minor effects on bioavailability and tumor uptake in mice models, whereas in-situ NEP-inhibition(s) by PA impressively improved in vivo profiles.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app